Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brausi

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary GroupM Brausi, W G Jones, S D Fosså, et al.
Urology|July 1, 1991
Recombinant alpha interferon in metastatic renal cell carcinoma. A cooperative phase II studyA V Bono, L Reali, C Benvenuti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary groupS D Fosså, P H Slee, M Brausi, et al.
Urologia Internationalis|August 30, 2014
The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcomeM Racioppi, L Salmaso, C Brombin, et al.
World Journal of Urology|January 7, 2015
Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus projectB G Muller, W van den Bos, M Brausi, et al.
Journal of Endourology|May 19, 2010
Focal therapy in prostate cancer-report from a consensus panelJ de la Rosette, H Ahmed, J Barentsz, et al.
World Journal of Urology|February 20, 2016
Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus projectA W Postema, T M De Reijke, O Ukimura, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
European Journal of Cancer (Oxford, England : 1990)|September 1, 1995
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary GroupM Brausi, W G Jones, S D Fosså, et al.
Urology|July 1, 1991
Recombinant alpha interferon in metastatic renal cell carcinoma. A cooperative phase II studyA V Bono, L Reali, C Benvenuti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary groupS D Fosså, P H Slee, M Brausi, et al.
Urologia Internationalis|August 30, 2014
The clinical use of statistical permutation test methodology: a tool for identifying predictive variables of outcomeM Racioppi, L Salmaso, C Brombin, et al.
World Journal of Urology|January 7, 2015
Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus projectB G Muller, W van den Bos, M Brausi, et al.
Journal of Endourology|May 19, 2010
Focal therapy in prostate cancer-report from a consensus panelJ de la Rosette, H Ahmed, J Barentsz, et al.
World Journal of Urology|February 20, 2016
Standardization of definitions in focal therapy of prostate cancer: report from a Delphi consensus projectA W Postema, T M De Reijke, O Ukimura, et al.
Pageof 4